Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion
- Conditions
- Nasal Congestion
- Interventions
- Device: Test stripDevice: Placebo stripOther: Nasal spray
- Registration Number
- NCT02275364
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
The aim of the study is to evaluate the effect of the nasal strip (relative to the placebo strip) on the nasal passages using anatomical MRI scans and to demonstrate the effect of the strip on breathing correlated cortical activity, using interoceptive fMRI task and analysis techniques derived from physiological data collected during scanning.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
- Participants with a self-rating of at least 3 to 8 for nasal congestion on the numerical rating scale
- Participants with a nasal congestion frequency score of 1, 2, 3 or 4.
- Evidence of obstructive nasal polyps, nasal tract structural malformations, visible open sores, sunburn, irritation, eczema or chronic skin condition on the face or nose
- Use of any medications like nasal decongestant, alpha adrenergic drugs, glucocorticoids and any current treatment which in the opinion of the investigator will affect nasal congestion
- Known or suspected intolerance or hypersensitivity to the study materials.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Placebo nasal strip Nasal spray Placebo nasal strip to be applied for up to two hours in either of the first two scans only. Test nasal strip Test strip Marketed Nasal Strip to be applied for up to two hours, and during the third scanning session for approximately 20 minutes. Placebo nasal strip Placebo strip Placebo nasal strip to be applied for up to two hours in either of the first two scans only. Test nasal strip Nasal spray Marketed Nasal Strip to be applied for up to two hours, and during the third scanning session for approximately 20 minutes.
- Primary Outcome Measures
Name Time Method Anatomical Measure: Volume (Single Volume Reading) Upto 2.5 hours Determination of single volume reading derived from examination of the nasal passages and sinuses, during the MRI.
Anatomical Measures : Cross Sectional Area Upto 2.5 hours Determination of cross sectional area derived from examination of the nasal passages and sinuses using T1 weighted MRI scans.
Anatomical Measures: Volume (Multiple Volume Reading) Upto 2.5 hours Determination of averaged volume reading during the MRI (Average of 8 sub-regions)
Functional Measure: Blood Oxygen Level Dependent- Interoceptive Attention Task (Psychophysiological Interactive Analysis) Upto 2.5 hours Regional measures of functional brain activity were to be derived from a breathing-related interoceptive task.
Functional Brain Activity: Blood Oxygen Level Dependent- Interoceptive Attention Task Upto 2.5 hours Regional measures of functional brain activity to be derived from a breathing-related interoceptive task. This outcome measure was pre-specified to analyze effect on nasal strips on the functional brain activity without the use of nasal decongestant.
Cerebral Blood Flow (CBF) Upto 2.5 hours CBF was derived from Arterial-Spin Labelling (ASL) scans. ASL data were analysed using custom Matlab code, which fits a CBF model to the raw perfusion data, in order to derive quantitative estimates of CBF in units of ml/100g/minute. The computed CBF maps were co-registered to the subject's whole-brain T1-weighted anatomical scan (from the first scan session) in order to spatially divide the data into anatomical Regions of Interest (ROIs). The anatomical ROIs were themselves defined by nonlinear warping of a standard cytoarchitectonic atlas into the space of the subject's T1 anatomical scan, using the FMRIB Software Library tool FNIRT. CBF data were extracted for a subset of these anatomical ROIs.
- Secondary Outcome Measures
Name Time Method Breathing-related Cortical Activity (Blood Oxygen Level Dependent- Resting State) Upto 2.5 hours Regional measures of breathing-related cortical activity were derived by determining Functional Connectivity and Event-related percentage signal change.
Functional connectivity analyzes of fMRI data where spontaneous (i.e. while the participant is at rest) signal changes in one brain region are regressed against other regions, to identify regions sharing similar functional properties.
Event-related functional magnetic resonance imaging (efMRI) detects changes in the BOLD hemodynamic response to neural activity associated with certain event. In this case, the events were pre-defined by collecting additional data during the scan; participant respiration was determined using a simple pressure-sensitive respiration belt. Events time-locked to peak inspiration and expiration were defined separately, and regressed against brain activity, showing brain regions that were more or less active during each event type.Verbal Numerical Response (VNR): Change From Baseline to Immediately After Strip Application and 30 Minutes Post Application Upto 30 minutes Participants provided their response for VNR on a scale of 0 to 10 (0 = Breathe Freely and 10 = Totally Blocked) how easy it was to breathe through nose at a given time.
VNR: Change From Baseline to 20 Minutes After Decongestant Administration, and Post Application of the Marketed Nasal Strip After Decongestant Administration Upto 2 hours Participants provided their response for VNR on a scale of 0 to 10 (0 = Breathe Freely and 10 = Totally Blocked) how easy it was to breathe through nose at a given time.
Trial Locations
- Locations (1)
Imanova Centre for Imaging Sciences
🇬🇧London, United Kingdom